|
🐜
|
Epidemiology of inclusion body myositis in the Netherlands: A nationwide study
16 auth.
U. Badrising,
M. Maat-Schieman,
S. V. Duinen,
F. Breedveld,
P. Doorn,
B. Engelen,
F. V. D. Hoogen,
J. Hoogendijk,
C. Höweler,
A. D. Jager,
...
F. Jennekens,
P. Koehler,
H. Leeuw,
M. Visser,
J. Verschuuren,
A. Wintzen
|
7 |
2000 |
7
🐜
|
|
🐜
|
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.
26 auth.
B. Rueda,
J. Broen,
C. Simeón,
R. Hesselstrand,
B. Díaz,
H. Suárez,
N. Ortego-Centeno,
G. Riemekasten,
V. Fonollosa,
M. Vonk,
F. V. D. Hoogen,
J. Sánchez-Román,
M. Aguirre-Zamorano,
R. García-Portales,
A. Pros,
...
M. Camps,
M. Gonzalez-gay,
M. Coenen,
P. Airò,
L. Beretta,
R. Scorza,
J. M. V. Laar,
M. González-Escribano,
J. Nelson,
T. Radstake,
J. Martin
|
7 |
2009 |
7
🐜
|
|
🐬
|
Right ventricle Tei-index: a tool to increase the accuracy of non-invasive detection of pulmonary arterial hypertension in connective tissue diseases.
M. Vonk,
M. Sander,
F. V. D. Hoogen,
P. Riel,
F. Verheugt,
A. Dijk
|
6 |
2007 |
6
🐬
|
|
🐜
|
Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
7 auth.
W. V. D. Hombergh,
S. Simons,
E. Teesselink,
H. Knaapen-Hans,
F. V. D. Hoogen,
Jaap Fransen,
...
M. Vonk
|
4 |
2018 |
4
🐜
|
|
🐢
|
Pulmonary hypertension: its diagnosis and management, a multidisciplinary approach.
M. Vonk,
A.P.J. van Dijk,
Y. Heijdra,
H. V. D. Heijden,
S. Bredie,
F. V. D. Hoogen
|
3 |
2005 |
3
🐢
|
|
🐜
|
Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial
44 auth.
Farge Dominique,
J. Laar,
J. Sont,
K. Naraghi,
Z. Marjanovic,
Jerome Largero,
A. Schuerwegh,
E. Marijt,
M. Vonk,
A. Schattenberg,
M. Matucci,
I. Miniati,
A. Voskuyl,
A. A. Loosdrecht,
T. Daikeler,
...
I. Koetter,
Marc Schmarlzing,
T. Martin,
S. Weiner,
C. Deligny,
J. Durand,
P. Emery,
K. Machold,
F. Sarrot-Reynauld,
K. Warnatz,
D. Adoue,
J. Constans,
H. Tony,
N. Papa,
A. Fassas,
A. Himsel,
D. Launay,
A. L. Monaco,
P. Philippe,
I. Quéré,
É. Rich,
R. Westhovens,
B. Griffiths,
R. Saccardi,
F. V. D. Hoogen,
W. Fibbe,
G. Socié,
A. Gratwohl,
A. Tyndall
|
3 |
2012 |
3
🐜
|
|
🦁
|
Arteriovenous shunting in quadriplegia
F. V. D. Hoogen,
L. Brawn,
S. Sherriff,
N. Watson,
J. Ward
|
2 |
1986 |
2
🦁
|
|
🐜
|
Epidemiology of inclusion body myositis in the Netherlands
15 auth.
U. Badrising,
M. Maat-Schieman,
S. Duinen,
P. Doorn,
B. Engelen,
F. V. D. Hoogen,
J. Hoogendijk,
C. Höweler,
A. D. Jager,
F. Jennekens,
...
P. Koehler,
H. Leeuw,
M. Visser,
J. Verschuuren,
A. Wintzen
|
2 |
1997 |
2
🐜
|
|
🐜
|
The onset and distribution of muscle weakness in inclusion body myositis (IBM)
15 auth.
U. Badrising,
M. Maat-Schieman,
S. Duinen,
P. Doorn,
B. Engelen,
F. V. D. Hoogen,
J. Hoogendijk,
C. Höweler,
Aej de Jager,
F. Jennekens,
...
P. Koehler,
H. Leeuw,
M. Visser,
J. Verschuuren,
A. Wintzen
|
0 |
1997 |
0
🐜
|
